Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06644378
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-15
Brief Title:
A Study of 14C-LY3866288 in Healthy Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-label 2-part Study of the Absorption Metabolism and Excretion and Absolute Bioavailability of 14C-LY3866288 in Healthy Participants
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study is to evaluate how much of the study drug LY3866288 administered as a single dose that has the radioactive substance 14C incorporated into it passes from blood into urine feces and expired air in healthy participants The study will also measure how much of the study drug gets into the bloodstream when taken orally compared to when injected directly into the vein how its broken down and how long it takes the body to get rid of it The study will also evaluate the safety and tolerability of LY3866288The study is conducted in two parts The study is expected to last approximately 68 days
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None